Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Biogen Inc. Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$3.1 Billion
Q3 2024

A detailed history of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H transactions in Biogen Inc. stock. As of the latest transaction made, Meag Munich Ergo, Kapitalanlagegesellschaft Mb H holds 518 shares of BIIB stock, worth $81,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares

518

Holding current value

$81,792

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$189.07 - $236.8 $97,938 - $122,662	518 New	518 $100,000
Q4 2023 Jan 19, 2024	SELL	$222.59 - $267.94 $284,915 - $342,963	-1,280 Reduced 76.42%	395 $102,000
Q3 2023 Oct 25, 2023	BUY	$253.3 - $285.89 $424,277 - $478,865	1,675 New	1,675 $430,000
Q3 2022 Oct 18, 2022	SELL	$194.69 - $268.46 $311,504 - $429,535	-1,600 Reduced 80.0%	400 $107,000
Q1 2022 Apr 13, 2022	SELL	$193.77 - $244.14 $4.55 Million - $5.73 Million	-23,459 Reduced 92.14%	2,000 $426,000
Q4 2021 Jan 25, 2022	BUY	$223.92 - $287.77 $495,311 - $636,547	2,212 Added 9.52%	25,459 $6.13 Million
Q3 2021 Oct 13, 2021	BUY	$282.99 - $369.05 $5.28 Million - $6.88 Million	18,641 Added 404.71%	23,247 $6.58 Million
Q2 2021 Jul 16, 2021	SELL	$259.0 - $414.71 $87,024 - $139,342	-336 Reduced 6.8%	4,606 $1.6 Million
Q1 2021 Apr 20, 2021	BUY	$242.95 - $284.63 $342,559 - $401,328	1,410 Added 39.92%	4,942 $1.38 Million
Q4 2020 Jan 20, 2021	SELL	$236.26 - $355.63 $370,455 - $557,627	-1,568 Reduced 30.75%	3,532 $860,000
Q3 2020 Oct 20, 2020	SELL	$264.77 - $305.71 $143,505 - $165,694	-542 Reduced 9.61%	5,100 $1.45 Million
Q2 2020 Jul 16, 2020	BUY	$258.66 - $342.55 $466,105 - $617,275	1,802 Added 46.93%	5,642 $1.51 Million
Q1 2020 Apr 23, 2020	SELL	$268.85 - $341.04 $565,122 - $716,866	-2,102 Reduced 35.38%	3,840 $1.22 Million
Q4 2019 Jan 17, 2020	SELL	$220.06 - $304.07 $2.22 Million - $3.06 Million	-10,066 Reduced 62.88%	5,942 $1.76 Million
Q3 2019 Oct 29, 2019	BUY	$217.44 - $243.88 $1.33 Million - $1.49 Million	6,126 Added 61.99%	16,008 $3.67 Million
Q2 2019 Jul 17, 2019	BUY	$219.29 - $241.72 $130,258 - $143,581	594 Added 6.4%	9,882 $2.37 Million
Q1 2019 Apr 29, 2019	BUY	$216.71 - $338.96 $1.07 Million - $1.67 Million	4,933 Added 113.27%	9,288 $2.16 Million
Q4 2018 Jan 29, 2019	BUY	$278.5 - $352.75 $178,240 - $225,760	640 Added 17.23%	4,355 $1.29 Million
Q3 2018 Oct 23, 2018	BUY	$293.51 - $383.83 $796,879 - $1.04 Million	2,715 Added 271.5%	3,715 $1.31 Million
Q2 2018 Jul 17, 2018	SELL	$257.52 - $306.91 $2.86 Million - $3.4 Million	-11,093 Reduced 91.73%	1,000 $291,000
Q1 2018 May 02, 2018	SELL	$260.13 - $367.91 $216,688 - $306,469	-833 Reduced 6.44%	12,093 $3.27 Million
Q4 2017 Jan 26, 2018	BUY	$307.64 - $344.58 $3.12 Million - $3.49 Million	10,126 Added 361.64%	12,926 $4.17 Million
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $787,219 - $923,132	2,800	2,800 $871,000

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Biogen Inc. Transaction History